about
Discrepancies between disk diffusion and broth susceptibility studies of the activity of ticarcillin plus clavulanic acid against ticarcillin-resistant Pseudomonas aeruginosaUse of ceftazidime in the therapy of serious infections, including those due to multiresistant organisms.Imipenem versus moxalactam in the treatment of serious infections.Pathogenicity of the enterococcus in surgical infections.Clinical consequences of development of resistance to third generation cephalosporins.Moxalactam in nosocomial infections with Serratia marcescens.
P2860
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Clinical evaluation of moxalactam.
@en
Clinical evaluation of moxalactam.
@nl
type
label
Clinical evaluation of moxalactam.
@en
Clinical evaluation of moxalactam.
@nl
prefLabel
Clinical evaluation of moxalactam.
@en
Clinical evaluation of moxalactam.
@nl
P2093
P2860
P356
P1476
Clinical evaluation of moxalactam.
@en
P2093
Finegold SM
Mathisen GE
Thompson JM
P2860
P304
P356
10.1128/AAC.21.5.780
P407
P577
1982-05-01T00:00:00Z